Site icon Duncan Bucknell

Problem patents in innovator pharma

In this recent European Biopharmaceutical Review article, Lee and Vandana analyse freedom to operate from the innovator perspective in the pharmaceutical and biotechnology areas.

Here’s a link to the pdf – Think IP Strategy EBR Summer 2010

Please do let us know what you think.

Exit mobile version